PlexBio Co., Ltd. (TPEX:6572)
Taiwan · Delayed Price · Currency is TWD 7.89
+0.12 (1.54%)
At close: Jan 22, 2026
PlexBio Revenue
PlexBio had revenue of 58.28M TWD in the half year ending June 30, 2025, a decrease of -39.81%. This brings the company's revenue in the last twelve months to 153.06M, up 47.69% year-over-year. In the year 2024, PlexBio had annual revenue of 128.06M, down -23.40%.
Revenue (ttm)
153.06M
Revenue Growth
+47.69%
P/S Ratio
5.26
Revenue / Employee
n/a
Employees
n/a
Market Cap
805.36M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 128.06M | -39.11M | -23.40% |
| Dec 31, 2023 | 167.18M | -24.01M | -12.56% |
| Dec 31, 2022 | 191.19M | 66.25M | 53.02% |
| Dec 31, 2021 | 124.94M | 23.60M | 23.28% |
| Dec 31, 2020 | 101.35M | 30.17M | 42.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Center Laboratories | 1.57B |
| Oneness Biotech | 117.33M |
| Polaris Group | 70.83M |
| Lumosa Therapeutics | 42.59M |
| Caliway Biopharmaceuticals | 34.99M |